kabutan

Kringle Pharma, First Half Net Income Loss Widens, Jan-Mar Net Income Loss Widens

Mon May 11, 2026 3:40 pm JST Earnings

4884 Kringle Pharma,Inc. 【J-GAAP】

Earnings Report

Kringle Pharma,Inc. <4884> [TSE Growth] announced its financial results after the market closed on May 11th (15:40). The net loss (non-consolidated) for the cumulative second quarter of the fiscal year ending September 2026 (October 2025 to March 2026) expanded to a loss of 516 million yen (compared to a loss of 512 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the April to September period (second half) is expected to expand to a loss of 504 million yen (compared to a loss of 404 million yen in the same period last year).

In the most recent three-month period, from January to March (2Q), the net loss expanded to a loss of 315 million yen (compared to a loss of 300 million yen in the same period last year). However, the operating profit/loss margin improved from -1758.8% in the same period last year to -1755.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Oct - Mar, 2023 43 -366 -365 -366 -60.2 ー May 13, 2024 J-GAAP
Oct - Mar, 2024 35 -511 -511 -512 -75.2 ー May 12, 2025 J-GAAP
Oct - Mar, 2025 36 -515 -513 -516 -71.4 ー May 11, 2026 J-GAAP
YoY +2.9% -0.8% -0.4% -0.8% +5.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Guidance ー ー ー ー － 0 Nov 12, 2025 J-GAAP
Oct - Mar, 2025 Results 36 -515 -513 -516 -71.4 0 May 11, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 37 -398 -403 -404 -59.1 0 Nov 12, 2025 J-GAAP
Apr - Sep, 2026 Guidance 296 -503 -505 -504 -68.2 0 May 11, 2026 J-GAAP
YoY +700.0% -26.4% -25.3% -24.8% -15.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 72 -909 -914 -916 -133.9 0 Nov 12, 2025 J-GAAP
Sep, 2026 Guidance 332 -1,018 -1,018 -1,020 -137.9 0 Mar 11, 2026 J-GAAP
YoY +361.1% -12.0% -11.4% -11.4% -3.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 17 -299 -299 -300 -44.0 -1,758.8 May 12, 2025 J-GAAP
Apr - Jun, 2025 18 -227 -227 -227 -33.3 -1,261.1 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 19 -171 -176 -177 -25.9 -900.0 Nov 12, 2025 J-GAAP
Oct - Dec, 2025 18 -199 -200 -201 -28.2 -1,105.6 Feb 9, 2026 J-GAAP
Jan - Mar, 2026 18 -316 -313 -315 -43.6 -1,755.6 May 11, 2026 J-GAAP
YoY +5.9% -5.7% -4.7% -5.0% +1.0%

Related Articles